|
|
Recent news from the US Food and Drug Administration.
Click title to see the full article at the FDA
website. For the most up-to-date headlines, check out the FDA
Newsroom. Press announcements from 2004 to 2009 are available through
the FDA
Archive.
FDA
Recalls: FDA posts press releases and other notices of recalls and
market withdrawals from the firms involved as a service to consumers,
the media, and other interested parties. FDA does not endorse either the
product or the company. This site does not contain a complete list of
recalls -
search for recalls at the official FDA site.
| September 30, 2025 - FDA
Conditionally Approves First Drug for Prevention and Treatment of
New World Screwworm Infestations in Cattle |
| September 30, 2025 - A
Statement From FDA Commissioner Marty Makary, M.D., M.P.H.: Encouraging
Retailers to Stop Selling Illegal Vapes |
| September 25, 2025 - FDA
Authorizes Marketing of First Eyeglass Lenses to Slow Progression
of Pediatric Myopia |
| September 25, 2025 - FDA
Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa
(vandetanib) |
| September 22, 2025 - FDA
Responds to Evidence of Possible Association Between Autism and Acetaminophen
Use During Pregnancy |
| September 22, 2025 - FDA
Takes Action to Make a Treatment Available for Autism Symptoms |
| September 19, 2025 - FDA
Grants Accelerated Approval to First Treatment for Barth Syndrome
|
| September 12, 2025 - FDA
Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic
Products |
| September 10, 2025 - HHS,
CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever
Operation |
| September 10, 2025 - FDA
Issues New Guidance to Expand Non-Opioid Options for Chronic Pain,
Curb Misuse |
| September 9, 2025 - FDA
Launches Crackdown on Deceptive Drug Advertising |
| September 5, 2025 - FDA
Approves Expanded Use of Vonvendi for von Willebrand Disease, Including
for Certain Uses for Children |
| September 5, 2025 - FDA
Launches Green List to Protect Americans from Illegal Imported GLP-1
Drug Ingredients |
| September 4, 2025 - FDA
Announces Real-Time Release of Complete Response Letters, Posts Previously
Unpublished Batch of 89 |
| September 3, 2025 - FDA
Advances Rare Disease Drug Development with New Evidence Principles |
| September 2, 2025 - FDA
Urges Nicotine Pouch Manufacturers To Use Child-Resistant Packaging
Following Increasing Reports of Accidental Exposure |
| August 22, 2025 - FDA
Begins Real-Time Reporting of Adverse Event Data |
| August 19, 2025 - HHS
Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm,
Protect U.S. Food Supply |
| August 14, 2025 - FDA
Approves First Immunotherapy for Recurrent Respiratory Papillomatosis |
| August 13, 2025 - Statement
from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction
of 7-OH Opioid Products |
| August 8, 2025 - FDA
Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization
of Orange Juice Regulations to Benefit American Growers |
| August 8, 2025 - A
Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing
Resolution of the IV Saline Solutions Shortage |
| August 7, 2025 - FDA
Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing |
| August 4, 2025 - FDA
Names Top HHS Lawyer as Chief Counsel |
See the current
MedSun newsletter at the FDA website for Recalls and Safety Alerts,
Highlighted Reports, and Links to FDA/CDRH Databases and Other Information
Sources.
- January
2025
- February 2025
- March 2025
- April 2025
- May 2025
- June 2025
- July 2025
- August 2025
- September 2025
- October 2025
- November 2025
- December 2025
|
|
